Fidelity Investments’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,782,567
| Closed | -$21M | – | 4437 |
|
|
2019
Q2 | $21M | Sell |
1,782,567
-5,652
| -0.3% | -$66.5K | ﹤0.01% | 1607 |
|
|
2019
Q1 | $24.4M | Buy |
1,788,219
+168,162
| +10% | +$2.3M | ﹤0.01% | 1512 |
|
|
2018
Q4 | $16.6M | Sell |
1,620,057
-474,034
| -23% | -$4.86M | ﹤0.01% | 1631 |
|
|
2018
Q3 | $34.9M | Sell |
2,094,091
-307,474
| -13% | -$5.12M | ﹤0.01% | 1448 |
|
|
2018
Q2 | $37.9M | Buy |
2,401,565
+427,600
| +22% | +$6.76M | ﹤0.01% | 1413 |
|
|
2018
Q1 | $25.1M | Buy |
1,973,965
+220,726
| +13% | +$2.8M | ﹤0.01% | 1623 |
|
|
2017
Q4 | $20.1M | Sell |
1,753,239
-2,552,068
| -59% | -$29.2M | ﹤0.01% | 1721 |
|
|
2017
Q3 | $52.7M | Sell |
4,305,307
-1,324,493
| -24% | -$16.2M | 0.01% | 1281 |
|
|
2017
Q2 | $64.5M | Sell |
5,629,800
-1,847,184
| -25% | -$21.2M | 0.01% | 1185 |
|
|
2017
Q1 | $156M | Sell |
7,476,984
-33,280
| -0.4% | -$692K | 0.02% | 802 |
|
|
2016
Q4 | $156M | Sell |
7,510,264
-17,468
| -0.2% | -$363K | 0.02% | 789 |
|
|
2016
Q3 | $247M | Buy |
7,527,732
+123,598
| +2% | +$4.05M | 0.03% | 575 |
|
|
2016
Q2 | $185M | Buy |
7,404,134
+840,549
| +13% | +$21M | 0.03% | 697 |
|
|
2016
Q1 | $161M | Buy |
6,563,585
+119,461
| +2% | +$2.93M | 0.02% | 752 |
|
|
2015
Q4 | $213M | Buy |
6,444,124
+409,278
| +7% | +$13.5M | 0.03% | 630 |
|
|
2015
Q3 | $198M | Sell |
6,034,846
-330,226
| -5% | -$10.8M | 0.03% | 640 |
|
|
2015
Q2 | $337M | Buy |
6,365,072
+5,597,094
| +729% | +$296M | 0.04% | 454 |
|
|
2015
Q1 | $22.2M | Buy |
767,978
+400,000
| +109% | +$11.5M | ﹤0.01% | 1690 |
|
|
2014
Q4 | $10.7M | Sell |
367,978
-399,626
| -52% | -$11.6M | ﹤0.01% | 1968 |
|
|
2014
Q3 | $9.73M | Hold |
767,604
| – | – | ﹤0.01% | 2026 |
|
|
2014
Q2 | $15.4M | Buy |
+767,604
| New | +$15.4M | ﹤0.01% | 1909 |
|